HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

I Salit Selected Research

Rifabutin (Ansamycin)

4/2000Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


I Salit Research Topics

Disease

1Acquired Immunodeficiency Syndrome (AIDS)
11/2006
1Onychomycosis (Tinea Unguium)
10/2000
1HIV Infections (HIV Infection)
04/2000

Drug/Important Bio-Agent (IBA)

1Carotenoids (Carotene)IBA
11/2006
1MicronutrientsIBA
11/2006
1Reverse Transcriptase InhibitorsIBA
10/2000
1Protease Inhibitors (Protease Inhibitor)IBA
10/2000
1Antifungal AgentsIBA
10/2000
1Rifampin (Rifampicin)FDA LinkGeneric
04/2000
1Ciprofloxacin (Cipro)FDA LinkGeneric
04/2000
1Clarithromycin (Biaxin)FDA LinkGeneric
04/2000
1Clofazimine (Lamprene)FDA Link
04/2000
1Ethambutol (Myambutol)FDA LinkGeneric
04/2000
1Rifabutin (Ansamycin)FDA Link
04/2000

Therapy/Procedure

1Ambulatory Care (Outpatient Care)
11/2006